Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Metabolic Solutions Development
AddedFeb 15, 2024
UpdatedJun 18, 2026
Metabolic Solutions Development

Metabolic Solutions Development

Series B

Michigan-based Metabolic Solutions develops insulin sensitizers for diabetes, liver, kidney, and neurodegenerative diseases.

HQ
Kalamazoo, MI, US
Founded
2011
Overview
Compare
Fundraising
Employees
Website

Metabolic Solutions Development Company (MSDC), based in Kalamazoo, Michigan, was founded with the mission to develop innovative therapeutics targeting metabolic diseases linked to age-related mitochondrial dysfunction. The company focuses on creating insulin sensitizers aimed at treating conditions such as type 2 diabetes, non-alcoholic fatty liver disease (NASH), polycystic kidney disease, and neurodegenerative diseases. Their core vision is to offer new hope for the prevention and treatment of these chronic conditions, serving patients across the United States.

Notable affiliated individuals include the executive team at Cirius Therapeutics, which completed a significant Series A financing round to fund a Phase 2b study of MSDC-0602K in NASH. This funding marks a key achievement for MSDC, enabling further development of their promising drug candidates. The company's impact lies in its potential to revolutionize treatment paradigms for metabolic diseases, addressing a critical need for effective therapies in these areas.

Metabolic Solutions Development - Similar Companies

Cirius Therapeutics logo

Cirius Therapeutics

ciriustx.com

EndoMetabolic Solutions logo

EndoMetabolic Solutions

endometabolic.com

Restor Metabolix logo

Restor Metabolix

KinDex Pharmaceuticals logo

KinDex Pharmaceuticals

MetaModix logo

MetaModix

Sensulin logo

Sensulin

sensulin.com

Microbiome Therapeutics logo

Microbiome Therapeutics

Glyscend logo

Glyscend

glyscend.com

Journeys Metabolic logo

Journeys Metabolic

Continuum Biosciences logo

Continuum Biosciences

NuSirt Sciences logo

NuSirt Sciences

nusirt.com

Elcelyx Therapeutics logo

Elcelyx Therapeutics

Syndevrx logo

Syndevrx

syndevrx.com

Agentix logo

Agentix

agentixcorp.com

GT Metabolic Solutions logo

GT Metabolic Solutions

gtmetabolic.com

Metabolic Solutions Development - Quick Facts

Who are Metabolic Solutions Development's competitors?

Companies similar to Metabolic Solutions Development include Cirius Therapeutics, EndoMetabolic Solutions, Restor Metabolix and KinDex Pharmaceuticals.

When was Metabolic Solutions Development founded?

Metabolic Solutions Development was founded in 2011.

Where is Metabolic Solutions Development's headquarters located?

Metabolic Solutions Development's headquarters is located in Kalamazoo, MI, US.

When was Metabolic Solutions Development's last funding round?

Metabolic Solutions Development's most recent funding round was for $16.1M (USD) in September 2015.

How much has Metabolic Solutions Development raised to-date?

As of Sep 25, 2015, Metabolic Solutions Development has raised a total of $58.5M (USD).

How many employees does Metabolic Solutions Development have?

Metabolic Solutions Development has 14 employees as of Feb 5, 2024.

Metabolic Solutions Development - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Insulin Sensitizers
  • Therapeutics
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified